account_balanceBalance Sheet (BS) Summary

Updated: 03/31/20262026 Q1

Total Assets

40.4M USD

YoY -33.0%

Shareholders' Equity

-10.7M USD

YoY -204.6%

Equity Ratio

-26.4%

YoY -43.4pt

Asset & Liability Mix

Non-current AssetsCurrent AssetsEquityNon-current LiabilitiesCurrent Liabilities

Equity Ratio Trend (5 Years)

Unit: %

21.510.50

2021

2022

2023

2024

2025

Balance Sheet Details

Unit: USD

Item

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

Cash

Cash and Equivalents

Short-term Investments

Net Receivables

Inventory

Other Current Assets

Total Current Assets

11.58M

0

1.13M

446,000

2.15M

15.31M

Goodwill

Intangible Assets

Property, Plant and Equipment

Property, Plant and Equipment Net

Long-term Investments

Other Assets

Other Non-current Assets

Net Tangible Assets

Non-current Assets Total

Total Assets

0

2.81M

607,000

0

7.03M

25.76M

10.45M

25.76M

Accounts Payable

Short-term Debt

Short/Current Long-term Debt

Current Deferred Revenue

Other Current Liabilities

Total Current Liabilities

2.54M

0

2.89M

12.07M

Long-term Debt

Long-term Debt Total

Capital Lease Obligations

Other Non-current Liabilities

Net Debt

Non-current Liabilities Total

Total Liabilities

0

3.50M

43.45M

-8.09M

45.15M

57.22M

Common Stock

Common Stock Shares Outstanding

Additional Paid-in Capital

Retained Earnings

Accumulated Other Comprehensive Income

Other Stockholder Equity

Treasury Stock

Total Stockholder Equity

369.21M

30.48M

0

-400.76M

86,000

0

-31.46M

Unlock Long-Term Balance Sheet Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan

Insight Molecular Diagnostics Inc.

account_balanceBalance Sheet (BS) Summary

Asset & Liability Mix

Equity Ratio Trend (5 Years)

Balance Sheet Details

Unlock Long-Term Balance Sheet Data